FindTrial
Sign In

Clinical Pharmacology Study of Z-100 - Study on Immunological Parameter in Healthy Adult -

Clinical Pharmacology Study of Z-100 - Study on Immunological Parameter in Healthy Adult -

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221848
Enrollment
120
Registered
2012-07-04
Start date
2012-07-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Interventions

investigational material(s) Generic name etc : Z-100 INN of investigational material : Therapeutic category code : 639 Other biological preparations Dosage and Administration for Investigational mate

Sponsors

Zeria Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Healthy adult -Body mass index of 17.6-26.4 kg/m2

Exclusion criteria

Exclusion criteria: -Subjects with allergy -Use of any medication within 1 week prior to administer

Design outcomes

Primary

MeasureTime frame
Immunological parameter—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026